Find uplifting stories about heroes, innovations, and solutions
7 results for "als treatment"
Amanda Sifford's lung capacity dropped to 48 percent before she received tofersen, a new drug that stopped her ALS decline and reversed her symptoms. Nearly 20 percent of patients in a three-year study showed improvement in breathing, strength, and function.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
A promising ALS treatment has enrolled its first patient in a major clinical trial that could slow disease progression. The drug showed encouraging results in early-stage patients during previous testing.
A groundbreaking ALS treatment has enrolled its first patient in a major clinical trial that could help slow disease progression in early-stage patients. The study follows encouraging results showing the drug helped preserve speech and breathing function in rapid-decline patients.
A new treatment for ALS significantly extended patient survival and delayed the need for breathing support in a Phase 2 trial, offering rare evidence of disease modification. AP-101 works by clearing toxic protein clumps that damage nerve cells in people with the fatal disease.
A University of Missouri researcher found a way to deliver healing molecules past the brain's protective barrier, improving ALS symptoms in mice. The breakthrough could lead to human trials that might one day prevent the disease before symptoms start.
Researchers in Belgium discovered how a common molecule called spermidine can restore damaged neurons in ALS, offering fresh hope for treating this devastating disease. The breakthrough could guide the development of new therapies for patients with amyotrophic lateral sclerosis.